ABCB1 and cancer: The combination of doxorubicin and taxol is often used at a lethal dose, and worse, the mixture often promotes the expression of MDR1 23, 24, 25, 26, 27, 28, 29, 30 (Fig. 3), which expels the drugs from cells and shields cancer cells from cytotoxicity.